Project liaison - united kingdom, tranent, east lothian

for 70 years, charles river employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. when you join our family, you will have a significant impact on the health and well-being of people across the globe. whether your background is in life sciences, finance, it, sales or another area, your skills will play an important role in the work we perform. in return, we'll help you build a career that you can feel passionate about.

**job summary**

charles river laboratories edinburgh, a leading contract research organisation with a specialism in safety assessment, are now looking for a dynamic problem solver to take on a critical role providing logistical oversight and support for studies and programmes of work.

as the *project liaison* you will work closely with all stakeholders, including client managers, to understand all aspects required for a particular study or package, and identify and monitor key milestones or deliverables in order to keep everything aligned.

working in close partnership with study management, study directors you will be pivotal to the success of client studies by utilising your exceptional influencing and communication skills and by proactively resolving conflicts or changes in the schedule whilst ensuring everyone is kept up to date.

highly organized with exemplary attention to detail you will demonstrate both drive and initiative, ensuring you fully represent the team in cross divisional meetings, and effectively communicate with other parties or sponsor as required.

this is a business critical role requiring a robust personality, who thrives in a busy multifaceted environment with the ability to be both assertive and diplomatic in order to achieve project deadlines and deliver results.

salary for this role will depend on skills and experience.

*

*about safety assessment*

charles river is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. from individual specialty toxicology and ind enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. each year approximately 300 investigational new drug (ind) programs are conducted in our safety assessment facilities.

*about charles river*

charles river is an early-stage contract research organization (cro). we have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both good laboratory practice (glp) and non-glp, to support clients from target identification through preclinical development. charles river also provides a suite of products and services to support our clients' clinical laboratory testing needs and manufacturing activities. utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

with over 17,000 employees within 90 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client's unique challenges. our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. and in 2019, revenue increased to $2.62 billion.

at charles river, we are passionate about our role in improving the quality of people's lives. our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. we have proudly supported the development of ~85% of the drugs approved by the fda in 2019.

More jobs